Healthcare Realty Trust (NYSE:HR) Issues FY24 Earnings Guidance

Healthcare Realty Trust (NYSE:HRGet Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $1.55-1.56 for the period, compared to the consensus EPS estimate of $1.55.

Healthcare Realty Trust Stock Performance

NYSE HR traded down $0.28 on Friday, reaching $16.90. The company’s stock had a trading volume of 7,754,980 shares, compared to its average volume of 3,478,413. The firm’s 50 day moving average is $17.88 and its two-hundred day moving average is $16.91. The stock has a market cap of $6.14 billion, a PE ratio of -10.70 and a beta of 0.91. Healthcare Realty Trust has a twelve month low of $12.77 and a twelve month high of $18.90.

Healthcare Realty Trust (NYSE:HRGet Free Report) last announced its quarterly earnings data on Friday, August 2nd. The real estate investment trust reported ($0.39) EPS for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.77). The company had revenue of $316.30 million for the quarter, compared to analyst estimates of $317.90 million. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. Healthcare Realty Trust’s revenue was down 6.4% on a year-over-year basis. During the same quarter last year, the company posted $0.39 EPS. Equities research analysts anticipate that Healthcare Realty Trust will post 1.55 EPS for the current fiscal year.

Healthcare Realty Trust Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Tuesday, November 12th will be given a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 7.34%. The ex-dividend date of this dividend is Tuesday, November 12th. Healthcare Realty Trust’s dividend payout ratio (DPR) is currently -78.48%.

Wall Street Analysts Forecast Growth

HR has been the topic of several recent analyst reports. Wells Fargo & Company reissued an “underweight” rating and set a $17.00 price target (up from $16.00) on shares of Healthcare Realty Trust in a research report on Tuesday, October 1st. Scotiabank increased their price target on shares of Healthcare Realty Trust from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Wednesday, August 7th. Finally, Wedbush boosted their price objective on shares of Healthcare Realty Trust from $15.00 to $18.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.17.

Read Our Latest Stock Analysis on Healthcare Realty Trust

Insider Activity at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian acquired 9,000 shares of the stock in a transaction dated Monday, August 12th. The shares were acquired at an average price of $17.39 per share, for a total transaction of $156,510.00. Following the completion of the purchase, the director now owns 22,252 shares in the company, valued at approximately $386,962.28. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Thomas N. Bohjalian purchased 9,000 shares of the stock in a transaction that occurred on Monday, August 12th. The shares were purchased at an average cost of $17.39 per share, for a total transaction of $156,510.00. Following the completion of the purchase, the director now directly owns 22,252 shares of the company’s stock, valued at approximately $386,962.28. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John Knox Singleton acquired 6,500 shares of Healthcare Realty Trust stock in a transaction on Thursday, September 5th. The stock was purchased at an average price of $18.24 per share, with a total value of $118,560.00. Following the transaction, the director now directly owns 57,082 shares in the company, valued at approximately $1,041,175.68. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 15,728 shares of company stock worth $279,069 in the last 90 days. 0.56% of the stock is owned by company insiders.

About Healthcare Realty Trust

(Get Free Report)

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Featured Stories

Earnings History and Estimates for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.